|
871 |
A randomized, double-blinded, placebo-controlled trial of the effects of infusing local analgesia on post-operative pain during laparoscopic inguinal hernia repair Enthalten in Surgical endoscopy and other interventional techniques 20.10.2022: 1-6
|
|
|
872 |
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis Enthalten in Pharmacopsychiatry 18.10.2022
|
|
|
873 |
Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial Enthalten in Nature medicine 17.10.2022: 1-2
|
|
|
874 |
A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge Enthalten in Psychopharmacology 15.10.2022: 1-13
|
|
|
875 |
The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Review and Meta-Analysis Enthalten in Drug research 10.10.2022
|
|
|
876 |
Lactobacillus-rhamnosus -Supplementation bei pädiatrischen Mukoviszidose-Patienten – nur das (Mikrobiom-) Ergebnis zählt? Enthalten in Karger-Kompass Pneumologie Bd. 10, 2022, Nr. 6: 298-300. 3 S.
|
|
|
877 |
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival Enthalten in Cancer immunology immunotherapy 5.10.2022: 1-10
|
|
|
878 |
Bullöses Pemphigoid: Ein small molecule zeigt großes Potenzial Enthalten in Karger-Kompass Dermatologie Bd. 10, 2022, Nr. 4: 181-183. 3 S.
|
|
|
879 |
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial Enthalten in Nature medicine 4.10.2022: 1
|
|
|
880 |
Atopische Dermatitis: Endlich kein Off-Label Use mehr bei Therapie im Kindesalter!? Enthalten in Karger-Kompass Dermatologie Bd. 10, 2022, Nr. 2: 70-72. 3 S.
|
|